| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DAY | Common Stock | Award | $0 | +4.36K | +23.13% | $0.00 | 23.2K | May 3, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DAY | Options (Right to Purchase) | 953 | May 3, 2024 | Common Stock | 953 | $65.26 | Direct | F3 | |||||
| holding | DAY | Options (Right to Purchase) | 5.93K | May 3, 2024 | Common Stock | 5.93K | $50.23 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | 4,363 shares of common stock of the Issuer ("Common Stock") that are issuable pursuant to restricted stock units ("RSUs"), granted on May 3, 2024, that vest as to 25% of the RSU on the last day of each three-month period commencing on the date of grant. |
| F2 | Includes (i) 17,821 shares of Common Stock; (ii) shares of Common Stock issuable pursuant to RSUs, granted on May 15, 2023, of which 1,046 shares vest on May 15, 2024; and (iii) 4,363 shares of Common Stock issuable pursuant to RSUs, granted on May 3, 2024, that vest as to 25% of the RSU on the last day of each three-month period commencing on the date of grant, the settlement of which the Reporting Person has elected to defer in accordance with the Dayforce, Inc. Non-Employee Director Deferral Program. |
| F3 | These options are fully vested and exercisable. |
Exhibit List 24. Power of Attorney